Stephanie Baum
Content Marketing Director at MedCity News
Director of Content Marketing at MedCity News, part of Breaking Media. Opinions expressed are my own. Can be reached at: [email protected]
Articles
-
1 week ago |
medcitynews.com | Stephanie Baum
It is a challenging time to be an early stage medtech or biopharma company. With the federal government funding cutbacks, entrepreneurs have to be resourceful and disciplined to support their strategy and reach their goals. A webinar sponsored by Mercury on Thursday, May 8 starting at 1 pm ET will feature early stage investors from Breyer Capital and MBX Capital, who will discuss the alternative funding opportunities that are available during this uncertain time.
-
1 week ago |
medcitynews.com | Stephanie Baum
Gaining greater insight into the patient journey from diagnosis through treatment is of great interest to drug developers as they aspire to produce more effective drugs. Using non-small cell lung cancer (NSCLC) as an example, PurpleLab and Genentech will explore how to leverage RWD to eliminate blind spots in the patient journey — informing every phase of a drug’s lifecycle, from clinical development to market access.
-
1 week ago |
medcitynews.com | Stephanie Baum
It can cost tens of millions to develop a medical device and bring it to market. It can take $1 billion or more to develop a drug. Companies that can facilitate the financial components of this process for early stage life science companies can ease the path to market.
-
1 week ago |
medcitynews.com | Stephanie Baum
Uncertainty dominates the healthcare spectrum, with the HHS led by the most anti-establishment head in modern times, Robert Kennedy Jr. It is sparking a lot of conversation about what the impact will be on vaccines, preventive care, health equity, and more. It’s the perfect time to attend our healthcare conference to speak with investors, startups and healthcare stakeholders to share perspectives and gain insight to plan for the future.
-
2 weeks ago |
medcitynews.com | Stephanie Baum
For 17 years, UnitedHealthcare built a solid track record of always meeting or surpassing earnings expectations. Until now, that is. Last month, the national health insurer disclosed it was $2 billion off its projected revenue. MedCity News Editor-in-Chief Arundhati Parmar and Samir Batra, managing partner of HIP (Health Innovation Pitch) observed that a big factor behind UnitedHealthcare’s poor results was a spike in medical utilization among Medicare Advantage members.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 6K
- Tweets
- 11K
- DMs Open
- No
RT @themaxburns: From the U.S. Holocaust Museum: "What distinguishes a concentration camp from a prison (in the modern sense) is that it f…
RT @PoliticsINQ: Delaware County becomes first Philly collar county to ban ghost guns https://t.co/UrQRuLmhzW
RT @JayCaruso: Important to keep this in mind when people tout tariffs as "patriotic." https://t.co/0Z27JK0NBI